BR112021012829A2 - Composições e métodos para modular o crescimento capilar - Google Patents

Composições e métodos para modular o crescimento capilar

Info

Publication number
BR112021012829A2
BR112021012829A2 BR112021012829A BR112021012829A BR112021012829A2 BR 112021012829 A2 BR112021012829 A2 BR 112021012829A2 BR 112021012829 A BR112021012829 A BR 112021012829A BR 112021012829 A BR112021012829 A BR 112021012829A BR 112021012829 A2 BR112021012829 A2 BR 112021012829A2
Authority
BR
Brazil
Prior art keywords
hair growth
methods
compositions
modulate hair
modulate
Prior art date
Application number
BR112021012829A
Other languages
English (en)
Inventor
Aimee Flores
R Christofk Heather
E Jung Michael
e lowry William
Xiaoguang Liu
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of BR112021012829A2 publication Critical patent/BR112021012829A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

composições e métodos para modular o crescimento capilar. a presente invenção refere-se a compostos que são capazes de inibir o carreador de piruvato mitocondrial e promover o crescimento do cabelo. a divulgação se ainda refere a métodos para promover o crescimento do cabelo ou tratar condições ou distúrbios que afetam o crescimento do cabelo, como calvície ou alopecia.
BR112021012829A 2019-01-02 2019-12-30 Composições e métodos para modular o crescimento capilar BR112021012829A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962787609P 2019-01-02 2019-01-02
PCT/US2019/068905 WO2020142413A1 (en) 2019-01-02 2019-12-30 Compositions and methods for modulating hair growth

Publications (1)

Publication Number Publication Date
BR112021012829A2 true BR112021012829A2 (pt) 2021-11-09

Family

ID=71406935

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021012829A BR112021012829A2 (pt) 2019-01-02 2019-12-30 Composições e métodos para modular o crescimento capilar

Country Status (13)

Country Link
US (1) US20220048908A1 (pt)
EP (1) EP3906240A4 (pt)
JP (1) JP2022516136A (pt)
KR (1) KR20210110817A (pt)
CN (1) CN113631555A (pt)
AR (1) AR117555A1 (pt)
AU (1) AU2019418584A1 (pt)
BR (1) BR112021012829A2 (pt)
CA (1) CA3124820A1 (pt)
IL (1) IL284397A (pt)
MX (1) MX2021008089A (pt)
SG (1) SG11202106471RA (pt)
WO (1) WO2020142413A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019010101A (es) 2017-02-24 2019-10-15 Univ California Composiciones y metodos para promover el crecimiento del cabello con inhibidores de mpc1.
JP7221227B2 (ja) 2017-06-30 2023-02-13 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 発毛を調節するための組成物及び方法
EP4172158A4 (en) * 2020-06-30 2024-01-10 The Regents of the University of California COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH
EP4172159A4 (en) * 2020-06-30 2024-01-10 The Regents of the University of California COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH
KR20230028924A (ko) 2021-08-23 2023-03-03 현대모비스 주식회사 차량용 램프 및 그 램프를 포함하는 차량
WO2023129854A1 (en) * 2021-12-29 2023-07-06 Pelage Pharmaceuticals, Inc. Compounds for treatment of hair loss
WO2023130024A1 (en) * 2021-12-29 2023-07-06 Pelage Pharmaceuticals, Inc. Compounds for treatment of hair loss
CN114949055A (zh) * 2022-02-10 2022-08-30 上海希尔维生物科技有限公司 栀子提取物和氧代戊二酸组合物及在防脱育发领域的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412719D0 (en) * 1994-06-24 1994-08-17 Erba Carlo Spa Substituted azaindolylidene compounds and process for their preparation
WO2015112854A1 (en) * 2014-01-24 2015-07-30 Confluence Life Sciences, Inc. Substituted pyroolopyridines and pyrrolopyrazines for treating cancer or inflammatory diseases
WO2018039612A1 (en) * 2016-08-26 2018-03-01 The Regents Of The University Of California Compositions and methods for promoting hair growth with mpc1 inhibitors
JP7221227B2 (ja) * 2017-06-30 2023-02-13 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 発毛を調節するための組成物及び方法

Also Published As

Publication number Publication date
MX2021008089A (es) 2021-08-05
SG11202106471RA (en) 2021-07-29
CA3124820A1 (en) 2020-07-09
IL284397A (en) 2021-08-31
AR117555A1 (es) 2021-08-11
WO2020142413A1 (en) 2020-07-09
CN113631555A (zh) 2021-11-09
EP3906240A4 (en) 2022-10-05
JP2022516136A (ja) 2022-02-24
AU2019418584A1 (en) 2021-07-08
KR20210110817A (ko) 2021-09-09
EP3906240A1 (en) 2021-11-10
US20220048908A1 (en) 2022-02-17

Similar Documents

Publication Publication Date Title
BR112021012829A2 (pt) Composições e métodos para modular o crescimento capilar
BR112019026080A8 (pt) Composições e métodos para modular o crescimento capilar
BR112022005826A2 (pt) Compostos de pirido[3,2-d]pirimidina como imunomoduladores
CO2019006622A2 (es) Derivados de pirazol como inhibidores de malt1
BR112017020999A2 (pt) inibidores de indolamina-2,3-dioxigenase para o tratamento de câncer
BR112015032595A8 (pt) inibidores de ido
BR112018068851A2 (pt) composto da fórmula, composição, métodos de combate ou controle de pragas invertebradas, de proteção de plantas e de tratamento ou proteção de animais, semente e uso de composto
CL2016000045A1 (es) Compuestos de n,6-bis(aril o heteroaril)-1,3,5-triazin-2,4-diamina como inhibidores de idh2 mutantes para el tratamiento de cáncer.
BR112015021999A8 (pt) inibidores de indoleamina 2,3-dioxigenase (ido), seus usos, composição farmacêutica, e método para inibir a atiavidade de indoleamina 2,3-dioxigenase
MX2016000295A (es) Inhibidores de indoleamina 2,3-dioxigenasa (ido).
BR112021022758A2 (pt) Compostos de 1-oxo-isoindolina-5-carboxamida substituídos, suas composições e métodos de tratamento com os mesmos
BR112017017349A2 (pt) composto, composição, método para tratar um distúrbio
PH12020500300A1 (en) Compositions and methods for modulating hair growth
UY37440A (es) Compuestos inhibidores de la prostaglandina d sintasa hematopoyética (h-pgds)
CL2021003513A1 (es) Compuestos heterocíclicos, como inhibidores de bet; composición, útil para tratar cáncer.
BR112019025548A2 (pt) Inibição ou redução do crescimento de plantas por biocimentação
CO2021001219A2 (es) Benzimidazoles sustituidos como inhibidores de pad4
BR112021017661A2 (pt) Uso de compostos 8,9-di-hidrocanabidiol
ECSP21003171A (es) Dinucleótidos cíclicos como agonistas de sting
MX370010B (es) Inhibidores de tirosina cinasa de bruton.
WO2019036417A3 (en) Inhibition of ngly1 for the treatment of cancer
MX2016006351A (es) Inhibidores de tirosina cinasa de bruton.
MX2023005716A (es) Derivados de cromeno como inhibidores de la interaccion receptor de antigeno de celula t (tcr) - region no catalitica de la proteina citosolica de la proteina tirosina cinasa (nck).
BR112017011281A2 (pt) composto, utilização, processo para o tingimento de fibras de queratina e composição
BR112023022883A2 (pt) Moduladores de pkc-teta